Flagship Thai hospital deal showcases Intouch’s Telehealth Platform ambitions

A major Bangkok hospital group is rolling out Intouch’s Telehealth Platform across its flagship facilities, highlighting how the Thai investment holding company is turning its digital-health unit into a core growth pillar alongside telecom assets.

Edited by ad hoc news Flagship & Bestseller Desk. Reviewed before publication on 06/15/2026 at 1:38 PM ET. Details in the imprint.

Thailand’s Intouch is stepping further into digital health as a flagship Bangkok hospital group expands use of the Intouch Telehealth Platform across its key facilities, positioning the software as a core tool for remote consultations and chronic-disease follow-up in the country’s urban centers. The platform, developed under Intouch’s digital portfolio, bundles video consultations, electronic medical records access and patient messaging into a single interface tailored for hospital workflows and Thai-language use.

How Intouch’s Telehealth Platform works inside hospitals

At its core, the Intouch Telehealth Platform is designed as a modular software stack that hospital IT teams can integrate with existing appointment, billing and electronic medical record systems rather than as a stand-alone direct-to-consumer app. According to Intouch’s own description of its digital-health business, the group focuses on software and platform solutions that plug into hospital partners, combining video visits, patient data management and analytics in one environment for clinicians on its digital-business overview. For hospital administrators, that architecture is central because it allows them to bolt teleconsultation capabilities onto existing systems instead of rebuilding IT from scratch.

The Bangkok deployment underscores that strategy. The hospital group is using the platform initially for follow-up consultations in specialties such as cardiology and endocrinology, where patients benefit from frequent contact without always needing in-person visits. Over time, the same software modules can be extended into triage and pre-admission screening, helping doctors decide which cases truly require hospital admission and which can be managed remotely at lower cost. Intouch highlights the ability to align the platform with national health-data regulations and privacy rules in Thailand, an important differentiator when set against generic global telemedicine apps that may not be localized to local compliance requirements.

On the patient side, the Telehealth Platform is accessed via a hospital-branded mobile or web interface, meaning users interact primarily with their familiar hospital brand while Intouch provides the underlying technology. That white-label structure fits Intouch’s role as a behind-the-scenes infrastructure provider rather than a consumer-facing medical brand. Patients can schedule virtual appointments, upload documents such as lab results or imaging reports and receive prescribed treatment plans after the consultation, while clinicians gain dashboards that surface key vital signs and notes from previous visits.

Intouch positions the telehealth business as a way to complement its telecom holdings, notably its strategic stake in AIS, by leveraging national connectivity to deliver healthcare services. In its latest corporate presentation, the company lists digital-health platforms alongside cloud and cybersecurity as the main pillars of its digital portfolio, indicating that the Telehealth Platform is viewed internally as part of a flagship growth vertical rather than a side experiment in its investor presentation. That framing matters: digital-health revenue is starting from a small base, but the group emphasizes recurring software and service fees instead of one-off project income.

While Intouch has not broken out specific pricing for its Telehealth Platform, regional hospital software deals of this type typically combine an implementation fee with ongoing per-seat or per-usage charges, giving the vendor more predictable revenue over time. The Bangkok rollout is also a reference case the company can point to when talking to other health providers both inside Thailand and in neighboring markets, where similar pressures on hospital capacity and an aging population drive interest in remote-care tools. If additional hospital chains adopt the same stack, Intouch will be able to scale relatively quickly, as most of the heavy lifting sits in software configuration and integration rather than new physical infrastructure deployment.

For Intouch, the Telehealth Platform sits within a broader push to pivot from being seen solely as a telecom holding toward a diversified digital and technology investor. The company explicitly identifies digital businesses, including healthcare, as one of its three core segments alongside telecom and “new business” in its public disclosures on the Stock Exchange of Thailand profile. Shares of Intouch Holdings (TH0904010016) are listed on the Stock Exchange of Thailand, where they last traded in Thai baht; the group is using its balance sheet and telecom connections to push digital-health offerings like the Telehealth Platform deeper into hospitals.

Intouch Telehealth Platform in brief

• Product: Intouch Telehealth Platform
• Manufacturer: Intouch Holdings Public Company Limited
• Category: Flagship digital-health software platform
• Launch date: Gradual rollout in the early 2020s, expanding with new hospital deployments
• MSRP / Price: Not publicly disclosed; typically contract-based software and service fees
• Availability: Deployed through partner hospitals in Thailand, with potential for regional expansion
• Target audience: Hospital groups, clinics and healthcare providers seeking integrated teleconsultation and remote-care tools
• Key differentiator / USP: White-label, hospital-integrated telehealth platform aligned with Thai regulations and backed by a telecom-linked digital investor

This article was a.i.-assisted and editorially reviewed. Product information without warranty; prices and availability may change at short notice. Not investment advice and not a buy or sell recommendation. Trading involves risk up to and including the total loss of invested capital.